🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › Montana

Urothelial (Transitional Cell) Carcinoma clinical trials in Montana

3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in Montana.

Cities in Montana

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Community Hospital of Anaconda, Anaconda
  • Billings Clinic Cancer Center, Billings
  • Bozeman Health Deaconess Hospital, Bozeman
  • and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Billings
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.